Literature DB >> 29882422

β-lactam antibiotics & vancomycin increase the growth & virulence of Candida spp.

Rossana de Aguiar Cordeiro1, Antonio José de Jesus Evangelista1, Rosana Serpa2, Ana Raquel Colares de Andrade1, Patrícia Bruna Leite Mendes1, Jônatas da Silva Franco1, Jonathas Sales de Oliveira1, Lucas Pereira de Alencar1, Jamille Alencar Sales1,3, Lília Maria Carneiro Câmara4, Débora de Souza Collares Maia Castelo-Branco1, Raimunda Sâmia Nogueira Brilhante1, José Júlio Costa Sidrim1, Marcos Fábio Gadelha Rocha1,3.   

Abstract

AIM: To investigate the direct effect of antibiotics on growth and virulence of the major Candida species associated with invasive infections. MATERIALS &
METHODS: Cefepime, imipenem, meropenem, amoxicillin and vancomycin were tested at twofold the peak plasma concentration (2× PP) and the peak plasma concentration (PP). The effects of antibiotics on Candida albicans, Candida parapsilosis, Candida krusei and Candida tropicalis were investigated by colony counting, flow cytometry, proteolytic activity and virulence in Caenorhabditis elegans.
RESULTS: Antibiotics increase growth and proteolytic activity of Candida spp; In addition, amoxicillin potentiates virulence of C. krusei and C. tropicalis against Caenorhabditis elegans.
CONCLUSION: These results suggest that antimicrobial therapy may have a direct effect on the pathophysiology of invasive fungal infections in patients at risk.

Entities:  

Keywords:  Candida spp.; antibiotics; virulence

Mesh:

Substances:

Year:  2018        PMID: 29882422     DOI: 10.2217/fmb-2018-0019

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  6 in total

Review 1.  Caenorhabditis elegans as a model animal for investigating fungal pathogenesis.

Authors:  Moses Madende; Jacobus Albertyn; Olihile Sebolai; Carolina H Pohl
Journal:  Med Microbiol Immunol       Date:  2019-09-25       Impact factor: 3.402

2.  FLO8 deletion leads to decreased adhesion and virulence with downregulated expression of EPA1, EPA6, and EPA7 in Candida glabrata.

Authors:  Jun-Tao Zhao; Ke-Zhi Chen; Jin-Yan Liu; Wei-Hua Li; Yu-Zhu Wang; Lu-Ling Wang; Ming-Jie Xiang
Journal:  Braz J Microbiol       Date:  2022-02-05       Impact factor: 2.214

Review 3.  Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2020-06-10       Impact factor: 4.003

Review 4.  Candida lusitaniae: Biology, Pathogenicity, Virulence Factors, Diagnosis, and Treatment.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes; Diana F Mendoza-Reyes
Journal:  Infect Drug Resist       Date:  2022-08-31       Impact factor: 4.177

Review 5.  Interactions between Candida albicans and the resident microbiota.

Authors:  Hao Li; Ming-Xing Miao; Cheng-Lin Jia; Yong-Bing Cao; Tian-Hua Yan; Yuan-Ying Jiang; Feng Yang
Journal:  Front Microbiol       Date:  2022-09-20       Impact factor: 6.064

Review 6.  Drug repurposing strategies in the development of potential antifungal agents.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Yingyu Mao; Zhangyong Song
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-21       Impact factor: 4.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.